Table 2.
Baseline data of the two groups
| Baseline data | EOF group, n = 105 | Control group, n = 101 | t value | P value |
| Gender, male/female, n | 88/17 | 86/15 | 0.005 | 0.942 |
| Age, yr | 61.69 ± 10.80 | 61.36 ± 11.72 | 1.387 | 0.167 |
| BMI, kg/m2 | 22.86 ± 4.70 | 23.15 ± 4.32 | -0.797 | 0.426 |
| NRS-2002 score , < 3 or ≥ 3, n | 41/64 | 38/63 | 0.034 | 0.872 |
| Preoperative serum PALB, mg/L | 227.50 ± 28.20 | 225.41 ± 23.60 | 1.269 | 0.264 |
| Preoperative serum ALB, g/L | 39.24 ± 4.36 | 38.58 ± 3.85 | 1.833 | 0.076 |
| Preoperative serum gastrin, ng/L | 212.40 ± 57.50 | 211.70 ± 53.80 | 1.512 | 0.134 |
| Preoperative serum motilin, ng/L | 358.40 ± 67.10 | 360.20 ± 68.70 | -1.946 | 0.071 |
| Operating time, min | 228.70 ± 31.20 | 225.90 ± 29.47 | 1.228 | 0.219 |
| Blood loss, mL | 155.68 ± 51.35 | 152.85 ± 52.46 | 1.294 | 0.211 |
| Pathological stage, n (%) | 0.014 | 0.913 | ||
| Stage I | 13 (12.38) | 11 (10.89) | ||
| Stage II | 48 (45.71) | 45 (44.55) | ||
| Stage III | 44 (41.91) | 45 (44.55) | ||
| Differentiation, n (%) | 0.008 | 0.930 | ||
| Poor | 52 (49.52) | 33 (49.25) | ||
| Moderate | 36 (34.29) | 23 (34.33) | ||
| Well | 17 (16.19) | 11 (16.42) | ||
| Borrmann types, n (%) | 0.221 | 0.694 | ||
| I | 8 (7.62) | 9 (8.91) | ||
| II | 34 (32.38) | 33 (32.67) | ||
| III | 47 (44.76) | 45 (44.56) | ||
| IV | 16 (15.24) | 14 (13.86) | ||
| Lauren types, n (%) | 0.675 | 0.407 | ||
| Intestinal type | 81 (77.14) | 74 (73.27) | ||
| Diffuse type | 24 (22.86) | 27 (26.73) |
EOF: Early oral feeding; BMI: Body mass index; NRS: Nutritional risk screening; PALB: Prealbumin; ALB: Albumin.